Intentionally being walked down today on low volume.
MNTA being walked down....a few thousand shares at a time. That can only mean one of two scenarios:
1. Leak of discussions = good news to follow soon on Copax and classic accumulation in progress, or
2. Dilution heading our way in the near future?
Jumped in today at $12.28 with a short term target of $19.
The reason for the plummeting stock price is that the Supreme Court granted cert to Teva in its patent infringement case against MNTA/Sandoz and Mylan. This could delay the US launch of generic versions of copaxone. Check DewDiligence's post on the IHUB board, or the IHUB board for MNTA, for further information.